SUMMARY In order to determine whether a diurnal variation in cholesterol saturation index is present in gall-bladder bile, samples of bile were taken by nasoduodenal intubation and cholecystokinin infusion at 9 am after the conventional 12 hour fast, and also at 5 pm five hours after a meal containing no cholesterol or phospholipid. In healthy controls saturation index (mean±SEM) fell from 102±0.08 at 9 am to 0-86±0*08 at 5 pm (n=8, p<005). In untreated cholesterol gall-stone patients saturation index fell from 1.30±0*07 to 1-04±0-07 (n=8, p<0.05); on chenodeoxycholic acid 15 mg/kg/day it fell from 0*91±0*06 to 0.78±0*07 (n=16, p<0.01). The degree of diurnal variation was similar in those taking chenodeoxycholic acid at bedtime and in those taking it at mealtimes. The 9 am sample was supersaturated in three non-responders (showing no evidence of gall stone dissolution on oral cholecystogram after at least six months treatment) and in four responders. The 5 pm sample was a better predictor of treatment failure, being supersaturated in all four non-responders but in only one out of the 12 responders (p<O-Ol).
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Cholesterol crystal formation in model bile solutions which are moderately supersaturated with cholesterol is slow, probably taking in the region of four to 28 hours.' Dissolution of cholesterol crystals in model bile solutions, however, is rapid at physiological biliary lipid compositions.2 If there were a marked diurnal variation in the cholesterol saturation index of gall-bladder bile, the slow induction and rapid dissolution of cholesterol crystals would tend to prevent formation of gall stones if the gall-bladder bile became unsaturated with cholesterol at some point during the day. A diurnal variation has been established for hepatic bile,3 but not for gall-bladder bile. We have, therefore, compared the saturation index of gallbladder bile obtained after the conventional overnight fast with that obtained at 5 pm only five hours after a meal. We have studied cholesterol gall-stone patients before and during treatment; and also control subjects without gall stones.
Methods

PATIENTS
We studied eight patients with radiolucent gall stones before treatment with chenodeoxycholic 
Results
In normal controls saturation index of gall-bladder bile fell from 102±008 (mean±SEM) at 9 am to 0O86±008 at 5 pm ( Fig. 1; p<005) . Diurnal variation for hepatic bile was greater quantitatively than for gall-bladder bile, as mean saturation index fell from 2-06 at 9 am to 1.30 at 5 pm, but the difference was not significant because these measurements were only carried out in five of the eight controls. In untreated cholesterol gall-stone patients saturation index of gall-bladder bile fell from 1-30±0-07 to 1-04±0-07 ( Fig. 1; p<0 (Fig. 2 ; p<O.OS); and on chenic acid 15 mglkg/day given at bedtime saturation index fell from 0.95±0-09 at 9 am to 0.80±0.10 at 5 pm ( Fig. 3; p<005) . The Fig. 2 ).
unsaturated gall-bladder bile at some time in the day than to check their effect on fasting gall-bladder bile in the morning. Evening samples in all four gall-stone patients who did not dissolve their stones on treatment were supersaturated, whereas in only one out of the 12 patients who showed gall stone dissolution was the evening sample supersaturated (p<001). The morning sample was not such a good predictor of response to treatment in that three of the morning samples were supersaturated with cholesterol in the non-responders and four in the responders.
We have previously shown that bedtime administration of chenic acid has a greater effect on saturation index of fasting gall-bladder bile than mealtime administration in the same subjects. 13 We have suggested that this is because bedtime administration prevents overnight interruption of the enterohepatic circulation of bile acids and thus reduces secretion of supersaturated nocturnal hepatic bile. An alternative explanation is the shorter time interval between bile acid administra- group.bmj.com on October 21, 2017 -Published by http://gut.bmj.com/ Downloaded from tion and sampling of the gall-bladder bile after the bedtime dose. The latter explanation implies that if gall-bladder bile was sampled later in the day in those receiving bedtime bile acid the difference in saturation index between the two treatment regimens would no longer be apparent. This latter explanation is contradicted by the finding in the present study that the degree of diurnal variation is at least as great in those receiving bedtime chenic acid (mean difference in saturation index 0.15) as those receiving mealtime chenic acid (mean 0.11). The fact that the actual saturation index on the bedtime regimen was not lower than on the mealtime regimen is attributable to the fact that two different groups of subjects were studied on this occasion, and that those receiving the bedtime regimen had a higher pretreatment saturation index (mean±SEM 1.21±0.07) than those receiving the mealtime regimen (1.02±0.10).
